Telomir ownership updated by John Paul DeJoria

Telomir Pharmaceuticals, Inc. is the subject of an amended beneficial ownership report by John Paul DeJoria, acting both as trustee of the John Paul DeJoria Family Trust and in his individual capacity.

Rhea-AI Filing Summary

Telomir Pharmaceuticals, Inc. is the subject of an amended beneficial ownership report by John Paul DeJoria, acting both as trustee of the John Paul DeJoria Family Trust and in his individual capacity. He reports beneficial ownership of 3,554,871 shares of Telomir common stock. This represents 5.169% of the common stock, based on 68,774,956 shares outstanding as of August 13, 2026, as referenced from Telomir’s quarterly report. DeJoria has sole voting and dispositive power over all 3,554,871 shares and no shared voting or dispositive power.

Key Figures

Shares beneficially owned: 3,554,871 shares Percent of class: 5.169% Shares outstanding: 68,774,956 shares +2 more

5 metrics

Shares beneficially owned 3,554,871 shares Common stock beneficially owned by John Paul DeJoria as of August 14, 2026

Percent of class 5.169% Percentage of Telomir common stock beneficially owned by John Paul DeJoria

Shares outstanding 68,774,956 shares Common shares outstanding as of August 13, 2026, referenced from Form 10-Q

Sole voting power 3,554,871 shares Shares over which John Paul DeJoria has sole power to vote or direct the vote

Shared voting power 0 shares Shares over which John Paul DeJoria has shared power to vote or direct the vote

Key Terms

beneficially owned, sole voting power, sole dispositive power, percent of class, +1 more

5 terms

beneficially owned financial

"The amount of shares of Common Stock reported as beneficially owned by the Reporting Person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 3,554,871.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 3,554,871.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

percent of class financial

"Percent of class: 5.169%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Power of Attorney regulatory

"EXHIBIT 24.1 Power of Attorney for John Paul DeJoria"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Telomir Pharmaceuticals (TELO) does John Paul DeJoria report owning?

John Paul DeJoria reports beneficial ownership of 5.169% of Telomir Pharmaceuticals’ common stock. This percentage is calculated based on 68,774,956 shares outstanding as of August 13, 2026, as referenced from the company’s quarterly report.

How many Telomir Pharmaceuticals (TELO) shares does John Paul DeJoria beneficially own?

John Paul DeJoria reports beneficial ownership of 3,554,871 shares of Telomir Pharmaceuticals common stock. He holds sole voting and dispositive power over all these shares, with no shared voting or dispositive power reported in the ownership disclosure.

As of what date is John Paul DeJoria’s Telomir (TELO) ownership information reported?

The beneficial ownership amount for John Paul DeJoria is reported as of August 14, 2026. The percentage calculation uses 68,774,956 shares outstanding as of August 13, 2026, as referenced from Telomir Pharmaceuticals’ Form 10-Q filed on that date.

Does John Paul DeJoria share voting power over his Telomir (TELO) shares?

No. John Paul DeJoria reports sole voting power over 3,554,871 shares and shared voting power of 0 shares. He likewise has sole dispositive power over the same number of shares with no shared dispositive authority reported.

In what capacity is John Paul DeJoria reporting his Telomir (TELO) ownership?

John Paul DeJoria reports ownership in a dual capacity: as trustee of the John Paul DeJoria Family Trust and in his individual capacity. The combined beneficial ownership for these capacities is 3,554,871 shares of Telomir common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:43 PM Accepted by SEC EDGAR 08/14/2026 - 04:40 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Telomir Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

87975F104

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 87975F104

1

Names of Reporting Persons

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,554,871.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,554,871.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,554,871.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.169 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The amount of shares of Common Stock reported as beneficially owned by the Reporting Person is based on the amount beneficially owned as of August 14, 2026. The percentage of shares of Common Stock reported as beneficially owned by the Reporting Person is based upon 68,774,956 shares of Common Stock outstanding as of August 13, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 13, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Telomir Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 100 SE 2nd Street, Suite 2000 #1009, Miami, FL 33131
Item 2.
(a)	Name of person filing: John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
(b)	Address or principal business office or, if none, residence: The business address of Mr. DeJoria is 109 West 7th Street, Suite 200, Georgetown, Texas 78626
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, no par value
(e)	CUSIP No.: 87975F104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,554,871
(b)	Percent of class: 5.169%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,554,871
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,554,871
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

Signature:	/s/ Matthew R. Bair
Name/Title:	Matthew R. Bair, Attorney-in-Fact
Date:	08/14/2026

Exhibit Information

EXHIBIT 24.1 Power of Attorney for John Paul DeJoria (Incorporated by reference).